Ingredion Inc
INGRWithin bandExpectations · demandingHeld by 3 superinvestors.
SEC 10-K · fundamentals
Business quality
as of 2025-12-31Valuation basis: trailing twelve months to 2026-06-30 — latest 10-K plus unaudited 10-Q filings.
- Revenue growth
- -2.8%
- Net margin
- 10.1%
- ROE
- 17.1%
- FCF margin
- 7.1%
Valuation · value band
In fair-value range
Zero-growth floor
$63
Central IV
$94
Optimistic top
$114
Ingredion Inc (INGR): A conservative value band $63–$114 / sh (zero-growth floor to growth-capped optimistic top); central read about $94. Today’s price sits inside that band (price $105 as of 2026-08-26).
The middle figure is the main read. The right end is the optimistic case under the same conservative caps — not an absolute ceiling.
Revenue growth 3% (lower of historical trend and fundamental cap, capped by moat) · moat 20 yr · discount 10.6% · Zero-growth downside $63
Price as of 2026-08-26 · yahoo · DGS10 4.6% @ 2026-08-25.
Method & numbers
A conservative intrinsic-value band (zero-growth floor to growth-capped DCF) plus a tangible asset floor — not investment advice, not a buy/sell signal, and not a price target.
Owner-earnings DCF $66.10 – $114.46 · Greenwald zero-growth $80.77 · zero-growth base $80.77 · reproduction $53.47
Moat Franchise (via earnings growth) · terminal value 21% of present value · owner-earnings yield 7% vs 10Y 4.6%.
Graham earnings-power value (normalized NOPAT)$63.41 – $80.40 / sh
Normalized NOPAT = average operating margin over the years shown × latest-year revenue × (1 − normalized tax); then + D&A − maintenance capex (write A). Unlevered (pre-interest, attributable to all capital). Capitalized at the 9–11% rate band (read as a WACC proxy). Enterprise → equity bridge applied: + cash − total debt.
Years: TTM 2026-06-30, 2024, 2023, 2022, 2021
v1 simplifications: Maintenance capex (degraded) deducted in full cash (write A): EPV = (NOPAT + D&A − maintenance capex) / WACC; no tax shield on the capex term. Maintenance-capex methods diverge by 116% (> 50%); estimate is degraded. Share-based compensation is left as a real expense (not added back).
Buffett owner-earnings value$66.08 – $80.77 / sh
Owner earnings = average net income + average D&A − maintenance capex (zero-growth floor; no ΔNWC). Levered (starts from net income, already after interest — an equity-holder stream). Capitalized at the 9–11% rate band (read as a cost-of-equity proxy). No enterprise→equity bridge: the capitalized result is already equity value (subtracting debt would double-count interest).
Years: TTM 2026-06-30, 2024, 2023, 2022, 2021
v1 simplifications: Owner earnings = net income + D&A − maintenance capex (degraded); the working-capital change is excluded (maintenance ΔNWC ≈ 0; growth ΔNWC is carried in growth value, not double-counted). Maintenance-capex methods diverge by 116% (> 50%); estimate is degraded. One-time items are not separately normalized (multi-year averaging smooths them partially). Share-based compensation is left as a real expense (not added back); see the SBC/OE disclosure. Capitalized at the 9–11% band as a cost-of-equity proxy; no leverage premium applied (net cash or debt within the no-charge range).
Reproduction value = tangible net assets $3.27B + capitalized R&D $146.80M（FY 2026, 2024, 2023, 2022） = $53.47 / sh. Reproduction value = tangible net assets (equity − goodwill − intangibles) + capitalized R&D (5y straight-line), ÷ diluted shares.
Moat reading: Franchise test compares earnings power (EPV) against reproduction value on both AV_conservative (tangible + capitalized R&D) and AV_reproduction (conservative + acquired-reset proxy). Both must clear the franchise multiple for a moat signal; near it, a commodity; below it, value destruction. A directional reading, not a verdict.
Assumes a wide moat · competitive-advantage period ≈ 20 years (earnings intact, ROIC stable over history).
Growth value gated to zero — franchise via earnings-growth bypass; growth credit stays in the owner-earnings DCF only.
Window TTM 2026-06-30, FY 2024, 2023, 2022, 2021 · discount band 9%–11% · normalized tax 21% (Average effective tax rate over 5 year(s), capped at the statutory 21%.) · diluted shares.
Owner-earnings DCF: growth g₁ 3% · OE FY TTM 2026-06-30, 2024, 2023, 2022, 2021 · Discount band: 9.14%–12.00% (DGS10 +4.5% to a 12% strict end, as of 2026-08-25). No enterprise→equity bridge: owner earnings already flow to shareholders (post-interest), so no net cash is added and no debt subtracted — matching the engine owner-earnings lamp.
Valuation basis: trailing twelve months to 2026-06-30 — latest 10-K plus unaudited 10-Q filings.
What the price is betting
Today's price pencils in about 4.8% a year in owner-earnings for the next few years. Revenue actually grew 3.4% a year.
The market wants it well ahead of its own track record.
SEC 13F · holders
Superinvestors Holding This Security
3 holders · $151.8M combined · this quarter +1 opened / -0 exited
- Value$139.4MWeight (prev→now)2.2% → 1.7% ▼
- Value$10.3MWeight (prev→now)0.0% → 0.0% ▲
- Value$2.2MWeight (prev→now)New · 0.0%
SEC 13F · notes
Written summary
Written summary
Ingredion Inc (INGR) is held by 3 of the superinvestors tracked on Compounder, with a combined $151.8M in reported 13F value. The largest position belongs to Donald Yacktman, where it makes up 1.7% of the portfolio.
Other notable holders by value include Ray Dalio (0.0% of its book) and Jeremy Grantham (0.0% of its book).
Over the latest quarter, 1 of the tracked filers opened a new position in INGR, 2 added to existing ones, 0 trimmed, and 0 sold out entirely.
Holder counts and values reflect the most recent SEC Form 13F filings, through the quarter ended 2026-06-30. Source: SEC EDGAR. A 13F shows only long US-listed positions and can lag the real portfolio by up to 45 days, so this is disclosed long ownership, not a complete picture.
SEC 13F · co-ownership
Also held by these investors
Investors holding Ingredion Inc (INGR) also commonly hold →
- Ss Spdr S&P 500 Etf Trust-UsSPY3 holders
- Microsoft CorpMSFT3 holders
- Johnson & JohnsonJNJ3 holders
- Unitedhealth Group IncUNH3 holders
- Visa Inc-Class A SharesV3 holders
- Coca-Cola Co/TheKO3 holders
INGR's price is not below its conservative value band. See current strike-zone stocks
Sources· SEC EDGAR 13F as of 2026-06-30 · filed 2026-08-14
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Stay Updated
New-quarter 13F moves and valuation updates, to your inbox.